Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank33
3Y CAGR+55.6%
5Y CAGR-19.6%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+55.6%/yr
vs -42.5%/yr prior
5Y CAGR
-19.6%/yr
Recent acceleration
Acceleration
+98.1pp
Accelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.40 | -97.9% |
| 2023 | 18.74 | +5382.5% |
| 2022 | 0.34 | +220.1% |
| 2021 | 0.11 | -71.8% |
| 2020 | 0.38 | -68.3% |
| 2019 | 1.19 | +116.5% |
| 2018 | 0.55 | -43.5% |
| 2017 | 0.98 | -53.4% |
| 2016 | 2.10 | +5.4% |
| 2015 | 1.99 | - |